12 February 2021 - PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March 2021.
1,800 people with multiple sclerosis will be able to stay on their treatment for longer, and some who had stopped funded treatment may now be eligible to restart.